Identification of an E3 ligase-encoding gene RFWD3 in non-small cell lung cancer
Yanfei Zhang1,2,3, Xinchun Zhao4, Yongchun Zhou5, Min Wang1,2, Guangbiao Zhou1,2,3()
1. State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China 2. State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China 3. University of Chinese Academy of Sciences, Beijing 100049, China 4. School of Life Sciences, University of Science and Technology of China, Hefei 230026, China 5. Department of Thoracic Surgery, the Third Affiliated Hospital of Kunming Medical University, Kunming 650106, China
In order to unveil ubiquitin pathway genes (UPGs) that are essential for non-small cell lung cancer (NSCLC) cell proliferation, we recently conducted a siRNA screening experiment to knockdown the expression of 696 UPGs found in the human genome in A549 and H1975 NSCLC cells. We found that silencing of one of the candidates, RFWD3 that encodes an E3 ubiquitin ligase essential for the repair of DNA interstrand cross-links in response to DNA damage, led to dramatic inhibition of NSCLC cell proliferation with significant Z-scores. Knockdown of RFWD3 suppressed colony forming activity of NSCLC cells. We further evaluated the significance of RFWD3 in NSCLCs and found that this gene was more elevated in tumor samples than in paired normal lung tissues and was inversely associated with the clinical outcome of patients with NSCLC. Moreover, RFWD3 expression was significantly higher in smokers than in non-smokers. These results show for the first time that RFWD3 is required for NSCLC cell proliferation and may have an important role in lung carcinogenesis.
D Wang, L Ma, B Wang, J Liu, W Wei. E3 ubiquitin ligases in cancer and implications for therapies. Cancer Metastasis Rev 2017; 36(4): 683–702 https://doi.org/10.1007/s10555-017-9703-z
pmid: 29043469
J Liu, S Shaik, X Dai, Q Wu, X Zhou, Z Wang, W Wei. Targeting the ubiquitin pathway for cancer treatment. Biochim Biophys Acta 2015; 1855(1): 50–60
pmid: 25481052
6
M Gabrielsen, L Buetow, MA Nakasone, SF Ahmed, GJ Sibbet, BO Smith, W Zhang, SS Sidhu, DT Huang. A general strategy for discovery of inhibitors and activators of RING and U-box E3 ligases with ubiquitin variants. Mol Cell 2017; 68(2): 456–470.e10 https://doi.org/10.1016/j.molcel.2017.09.027
pmid: 29053960
7
JJ Mu, Y Wang, H Luo, M Leng, J Zhang, T Yang, D Besusso, SY Jung, J Qin. A proteomic analysis of ataxia telangiectasia-mutated (ATM)/ATM-Rad3-related (ATR) substrates identifies the ubiquitin-proteasome system as a regulator for DNA damage checkpoints. J Biol Chem 2007; 282(24): 17330–17334 https://doi.org/10.1074/jbc.C700079200
pmid: 17478428
8
X Fu, N Yucer, S Liu, M Li, P Yi, JJ Mu, T Yang, J Chu, SY Jung, BW O’Malley, W Gu, J Qin, Y Wang. RFWD3-Mdm2 ubiquitin ligase complex positively regulates p53 stability in response to DNA damage. Proc Natl Acad Sci USA 2010; 107(10): 4579–4584 https://doi.org/10.1073/pnas.0912094107
pmid: 20173098
S Liu, J Chu, N Yucer, M Leng, SY Wang, BPC Chen, WN Hittelman, Y Wang. RING finger and WD repeat domain 3 (RFWD3) associates with replication protein A (RPA) and facilitates RPA-mediated DNA damage response. J Biol Chem 2011; 286(25): 22314–22322 https://doi.org/10.1074/jbc.M111.222802
pmid: 21558276
11
K Knies, S Inano, MJ Ramírez, M Ishiai, J Surrallés, M Takata, D Schindler. Biallelic mutations in the ubiquitin ligase RFWD3 cause Fanconi anemia. J Clin Invest 2017; 127(8): 3013–3027 https://doi.org/10.1172/JCI92069
pmid: 28691929
12
JS Mitchell, N Li, N Weinhold, A Försti, M Ali, M van Duin, G Thorleifsson, DC Johnson, B Chen, BM Halvarsson, DF Gudbjartsson, R Kuiper, OW Stephens, U Bertsch, P Broderick, C Campo, H Einsele, WA Gregory, U Gullberg, M Henrion, J Hillengass, P Hoffmann, GH Jackson, E Johnsson, M Jöud, SY Kristinsson, S Lenhoff, O Lenive, UH Mellqvist, G Migliorini, H Nahi, S Nelander, J Nickel, MM Nöthen, T Rafnar, FM Ross, MI da Silva Filho, B Swaminathan, H Thomsen, I Turesson, A Vangsted, U Vogel, A Waage, BA Walker, AK Wihlborg, A Broyl, FE Davies, U Thorsteinsdottir, C Langer, M Hansson, M Kaiser, P Sonneveld, K Stefansson, GJ Morgan, H Goldschmidt, K Hemminki, B Nilsson, RS Houlston. Genome-wide association study identifies multiple susceptibility loci for multiple myeloma. Nat Commun 2016; 7: 12050 https://doi.org/10.1038/ncomms12050
pmid: 27363682
13
CC Chung, PA Kanetsky, Z Wang, MAT Hildebrandt, R Koster, RI Skotheim, CP Kratz, C Turnbull, VK Cortessis, AC Bakken, DT Bishop, MB Cook, RL Erickson, SD Fosså, KB Jacobs, LA Korde, SM Kraggerud, RA Lothe, JT Loud, N Rahman, EC Skinner, DC Thomas, X Wu, M Yeager, FR Schumacher, MH Greene, SM Schwartz, KA McGlynn, SJ Chanock, KL Nathanson. Meta-analysis identifies four new loci associated with testicular germ cell tumor. Nat Genet 2013; 45(6): 680–685 https://doi.org/10.1038/ng.2634
pmid: 23666239
14
DL Zhang, LW Qu, L Ma, YC Zhou, GZ Wang, XC Zhao, C Zhang, YF Zhang, M Wang, MY Zhang, H Yu, BB Sun, SH Gao, X Cheng, MZ Guo, YC Huang, GB Zhou. Genome-wide identification of transcription factors that are critical to non-small cell lung cancer. Cancer Lett 2018; 434: 132–143 https://doi.org/10.1016/j.canlet.2018.07.020
pmid: 30031117
15
N Malo, JA Hanley, S Cerquozzi, J Pelletier, R Nadon. Statistical practice in high-throughput screening data analysis. Nat Biotechnol 2006; 24(2): 167–175 https://doi.org/10.1038/nbt1186
pmid: 16465162
16
XC Zhao, GZ Wang, YC Zhou, J Liu, L Ma, C Zhang, DL Zhang, SH Gao, LW Qu, B Zhang, CL Wang, YC Huang, L Chen, GB Zhou. Genome-wide identification of CDC34 that stabilizes EGFR and promotes lung carcinogenesis. bioRxiv 2018 https://doi.org/10.1101/255844
17
DR Rhodes, S Kalyana-Sundaram, V Mahavisno, R Varambally, J Yu, BB Briggs, TR Barrette, MJ Anstet, C Kincead-Beal, P Kulkarni, S Varambally, D Ghosh, AM Chinnaiyan. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 2007; 9(2): 166–180 https://doi.org/10.1593/neo.07112
pmid: 17356713
18
J Hou, J Aerts, B den Hamer, W van Ijcken, M den Bakker, P Riegman, C van der Leest, P van der Spek, JA Foekens, HC Hoogsteden, F Grosveld, S Philipsen. Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One 2010; 5(4): e10312 https://doi.org/10.1371/journal.pone.0010312
pmid: 20421987
19
SA Selamat, BS Chung, L Girard, W Zhang, Y Zhang, M Campan, KD Siegmund, MN Koss, JA Hagen, WL Lam, S Lam, AF Gazdar, IA Laird-Offringa. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression. Genome Res 2012; 22(7): 1197–1211 https://doi.org/10.1101/gr.132662.111
pmid: 22613842
20
MT Landi, T Dracheva, M Rotunno, JD Figueroa, H Liu, A Dasgupta, FE Mann, J Fukuoka, M Hames, AW Bergen, SE Murphy, P Yang, AC Pesatori, D Consonni, PA Bertazzi, S Wacholder, JH Shih, NE Caporaso, J Jen. Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS One 2008; 3(2): e1651 https://doi.org/10.1371/journal.pone.0001651
pmid: 18297132
21
H Okayama, T Kohno, Y Ishii, Y Shimada, K Shiraishi, R Iwakawa, K Furuta, K Tsuta, T Shibata, S Yamamoto, S Watanabe, H Sakamoto, K Kumamoto, S Takenoshita, N Gotoh, H Mizuno, A Sarai, S Kawano, R Yamaguchi, S Miyano, J Yokota. Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res 2012; 72(1): 100–111 https://doi.org/10.1158/0008-5472.CAN-11-1403
pmid: 22080568
22
S Wachi, K Yoneda, R Wu. Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues. Bioinformatics 2005; 21(23): 4205–4208 https://doi.org/10.1093/bioinformatics/bti688
pmid: 16188928
23
RS Stearman, L Dwyer-Nield, L Zerbe, SA Blaine, Z Chan, PA Bunn Jr, GL Johnson, FR Hirsch, DT Merrick, WA Franklin, AE Baron, RL Keith, RA Nemenoff, AM Malkinson, MW Geraci. Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model. Am J Pathol 2005; 167(6): 1763–1775 https://doi.org/10.1016/S0002-9440(10)61257-6
pmid: 16314486
24
TP Lu, MH Tsai, JM Lee, CP Hsu, PC Chen, CW Lin, JY Shih, PC Yang, CK Hsiao, LC Lai, EY Chuang. Identification of a novel biomarker, SEMA5A, for non-small cell lung carcinoma in nonsmoking women. Cancer Epidemiol Biomarkers Prev 2010; 19(10): 2590–2597 https://doi.org/10.1158/1055-9965.EPI-10-0332
pmid: 20802022
25
L Ma, Y Huang, W Zhu, S Zhou, J Zhou, F Zeng, X Liu, Y Zhang, J Yu. An integrated analysis of miRNA and mRNA expressions in non-small cell lung cancers. PLoS One 2011; 6(10): e26502 https://doi.org/10.1371/journal.pone.0026502
pmid: 22046296
26
H Okayama, T Kohno, Y Ishii, Y Shimada, K Shiraishi, R Iwakawa, K Furuta, K Tsuta, T Shibata, S Yamamoto, S Watanabe, H Sakamoto, K Kumamoto, S Takenoshita, N Gotoh, H Mizuno, A Sarai, S Kawano, R Yamaguchi, S Miyano, J Yokota. Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res 2012; 72(1): 100–111 https://doi.org/10.1158/0008-5472.CAN-11-1403
pmid: 22080568
27
MC Tai, T Kajino, M Nakatochi, C Arima, Y Shimada, M Suzuki, H Miyoshi, Y Yatabe, K Yanagisawa, T Takahashi. miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer. Carcinogenesis 2015; 36(12): 1464–1473 https://doi.org/10.1093/carcin/bgv152
pmid: 26483346
28
B Győrffy, P Surowiak, J Budczies, A Lánczky. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS One 2013; 8(12): e82241 https://doi.org/10.1371/journal.pone.0082241
pmid: 24367507
29
ES Lee, DS Son, SH Kim, J Lee, J Jo, J Han, H Kim, HJ Lee, HY Choi, Y Jung, M Park, YS Lim, K Kim, Y Shim, BC Kim, K Lee, N Huh, C Ko, K Park, JW Lee, YS Choi, J Kim. Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression. Clin Cancer Res 2008; 14(22): 7397–7404 https://doi.org/10.1158/1078-0432.CCR-07-4937
pmid: 19010856
30
J Staaf, G Jönsson, M Jönsson, A Karlsson, S Isaksson, A Salomonsson, HM Pettersson, M Soller, SB Ewers, L Johansson, P Jönsson, M Planck. Relation between smoking history and gene expression profiles in lung adenocarcinomas. BMC Med Genomics 2012; 5(1): 22 https://doi.org/10.1186/1755-8794-5-22
pmid: 22676229
31
T Ravid, M Hochstrasser. Diversity of degradation signals in the ubiquitin-proteasome system. Nat Rev Mol Cell Biol 2008; 9(9): 679–689 https://doi.org/10.1038/nrm2468
pmid: 18698327
K Kok, R Hofstra, A Pilz, A van den Berg, P Terpstra, CH Buys, B Carritt. A gene in the chromosomal region 3p21 with greatly reduced expression in lung cancer is similar to the gene for ubiquitin-activating enzyme. Proc Natl Acad Sci USA 1993; 90(13): 6071–6075 https://doi.org/10.1073/pnas.90.13.6071
pmid: 8327486
34
P Pallante, U Malapelle, MT Berlingieri, C Bellevicine, R Sepe, A Federico, D Rocco, M Galgani, L Chiariotti, M Sanchez-Cespedes, A Fusco, G Troncone. UbcH10 overexpression in human lung carcinomas and its correlation with EGFR and p53 mutational status. Eur J Cancer 2013; 49(5): 1117–1126 https://doi.org/10.1016/j.ejca.2012.09.033
pmid: 23102841
35
H Kadara, L Lacroix, C Behrens, L Solis, X Gu, JJ Lee, E Tahara, D Lotan, WK Hong, II Wistuba, R Lotan. Identification of gene signatures and molecular markers for human lung cancer prognosis using an in vitro lung carcinogenesis system. Cancer Prev Res (Phila) 2009; 2(8): 702–711 https://doi.org/10.1158/1940-6207.CAPR-09-0084
pmid: 19638491
YHC Tan, S Krishnaswamy, S Nandi, R Kanteti, S Vora, K Onel, R Hasina, FY Lo, E El-Hashani, G Cervantes, M Robinson, HS Hsu, SC Kales, S Lipkowitz, T Karrison, M Sattler, EE Vokes, YC Wang, R Salgia. CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases. PLoS One 2010; 5(1): e8972 https://doi.org/10.1371/journal.pone.0008972
pmid: 20126411
38
AU Ahmed, RL Schmidt, CH Park, NR Reed, SE Hesse, CF Thomas, JR Molina, C Deschamps, P Yang, MC Aubry, AH Tang. Effect of disrupting seven-in-absentia homolog 2 function on lung cancer cell growth. J Natl Cancer Inst 2008; 100(22): 1606–1629 https://doi.org/10.1093/jnci/djn365
pmid: 19001609
39
JJ Sacco, TY Yau, S Darling, V Patel, H Liu, S Urbé, MJ Clague, JM Coulson. The deubiquitylase Ataxin-3 restricts PTEN transcription in lung cancer cells. Oncogene 2014; 33(33): 4265–4272 https://doi.org/10.1038/onc.2013.512
pmid: 24292675
40
S Byun, SY Lee, J Lee, CH Jeong, L Farrand, S Lim, K Reddy, JY Kim, MH Lee, HJ Lee, AM Bode, K Won Lee, Z Dong. USP8 is a novel target for overcoming gefitinib resistance in lung cancer. Clin Cancer Res 2013; 19(14): 3894–3904 https://doi.org/10.1158/1078-0432.CCR-12-3696
pmid: 23748694
41
C McFarlane, S McFarlane, I Paul, K Arthur, M Scheaff, K Kerr, M Stevenson, DA Fennell, JA Johnston. The deubiquitinating enzyme USP17 is associated with non-small cell lung cancer (NSCLC) recurrence and metastasis. Oncotarget 2013; 4(10): 1836–1843 https://doi.org/10.18632/oncotarget.1282
pmid: 24123619
42
J Pan, Q Deng, C Jiang, X Wang, T Niu, H Li, T Chen, J Jin, W Pan, X Cai, X Yang, M Lu, J Xiao, P Wang. USP37 directly deubiquitinates and stabilizes c-Myc in lung cancer. Oncogene 2015; 34(30): 3957–3967 https://doi.org/10.1038/onc.2014.327
pmid: 25284584
43
YQ Liu, XL Wang, X Cheng, YZ Lu, GZ Wang, XC Li, J Zhang, ZS Wen, ZL Huang, QL Gao, LN Yang, YX Cheng, SC Tao, J Liu, GB Zhou. Skp1 in lung cancer: clinical significance and therapeutic efficacy of its small molecule inhibitors. Oncotarget 2015; 6(33): 34953–34967 https://doi.org/10.18632/oncotarget.5547
pmid: 26474281
44
YC Lin, Y Wang, R Hsu, S Giri, S Wopat, MK Arif, A Chakraborty, KV Prasanth, SG Prasanth. PCNA-mediated stabilization of E3 ligase RFWD3 at the replication fork is essential for DNA replication. Proc Natl Acad Sci USA 2018; 115(52): 13282–13287 https://doi.org/10.1073/pnas.1814521115
pmid: 30530694
45
S Inano, K Sato, Y Katsuki, W Kobayashi, H Tanaka, K Nakajima, S Nakada, H Miyoshi, K Knies, A Takaori-Kondo, D Schindler, M Ishiai, H Kurumizaka, M Takata. RFWD3-mediated ubiquitination promotes timely removal of both RPA and RAD51 from DNA damage sites to facilitate homologous recombination. Mol Cell 2017; 66(5): 622–634.e8 https://doi.org/10.1016/j.molcel.2017.04.022
pmid: 28575658
46
L Feeney, IM Muñoz, C Lachaud, R Toth, PL Appleton, D Schindler, J Rouse. RPA-mediated recruitment of the E3 ligase RFWD3 is vital for interstrand crosslink repair and human health. Mol Cell 2017; 66(5): 610–621.e4 https://doi.org/10.1016/j.molcel.2017.04.021
pmid: 28575657
47
World Health Organization. Ambient (outdoor) air quality and health. . 2018. Accessed November 22, 2018
48
World Health Organization. Household air pollution and health. . 2018. Accessed December 24, 2018
49
World Health Organization. Tobacco fact sheet. . 2019. Accessed December 24, 2018
50
LB Alexandrov, YS Ju, K Haase, P Van Loo, I Martincorena, S Nik-Zainal, Y Totoki, A Fujimoto, H Nakagawa, T Shibata, PJ Campbell, P Vineis, DH Phillips, MR Stratton. Mutational signatures associated with tobacco smoking in human cancer. Science 2016; 354(6312): 618–622 https://doi.org/10.1126/science.aag0299
pmid: 27811275
51
R Govindan, L Ding, M Griffith, J Subramanian, ND Dees, KL Kanchi, CA Maher, R Fulton, L Fulton, J Wallis, K Chen, J Walker, S McDonald, R Bose, D Ornitz, D Xiong, M You, DJ Dooling, M Watson, ER Mardis, RK Wilson. Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell 2012; 150(6): 1121–1134 https://doi.org/10.1016/j.cell.2012.08.024
pmid: 22980976